The experienced guide for cell & gene therapy manufacturing
SCTbio is the leader in services, development and cGMP production of cell-based therapies and retroviruses vectors, with the experience to be your high-quality and accessible CDMO partner. SCTbio is supported by PPF Group.
What can the right cell therapy CDMO partner do for you?
What sets SCTbio apart is the people. Unlike large CDMOs, SCTbio’s staff is intensely client-focused, with the forethought to ask the right questions, the wisdom to listen carefully to a partner’s needs, and the experience to offer innovative solutions.
We also have specialized expertise in cell-based products, including dendritic cell therapeutics and other genetically modified constructs such as CAR-T, as well as lentiviral and gammaretroviral vector production used for the modification of the cellular products.
SCTbio delivers the highest quality collaboration through a range of services ensuring GMP compliance for the full life cycle of drug development, that include technology transfers, process development, clinical manufacturing services, fill & finish, quality control, QA/QP release, storage and logistics.
Unique Global Network of Apheresis Centers
SCTbio has established close cooperation with Apheresis Centers in Europe and the USA and can provide support in setting up the appropriate procedures within a network of 150 qualified and regularly monitored cell-collection sites.